The FDA has approved the use of an antibody cocktail to treat severe coronavirus cases. Previously, US President Donald Trump was treated with this drug.
Regeneron Pharmaceuticals’ experimental drug REGN-COV2 for emergency coronavirus infection has been approved by the US Food and Drug Administration (FDA). US President Donald Trump took the same drug – it is also called the “cocktail of antibodies.”
It is a mixture of two monoclonal antibodies – basiliximab and imdevimab. The US Food and Drug Administration said the cocktail might be effective in treating mild to moderate coronavirus in adults and children 12 years and older but should be given primarily to patients at high risk of developing a serious illness. Doctors hope the drug will keep these patients from being hospitalized.
Clinical studies have already shown that it reduces hospitalizations due to COVID-19 and reduces the risk of disease progression. However, researchers have not yet fully evaluated the safety of the drug.
Earlier, Trump announced that he would seek early approval of the “cocktail” after he himself was convinced that the drug works. He believes that the drug should be delivered to hospitals.
In the United States, more than 12 million people have been infected with the coronavirus. By November 22, 12 million 38 thousand infections have been confirmed in the United States. The country still ranks first in the world for this indicator. The number of deaths is 255.5 thousand.